Advanced prostate cancer cases in California are rising faster than the national average, according to a UCSF study. Experts ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

Updated data from the Phase III TALAPRO-2 trial show that the combination of Talzenna (talazoparib) and Xtandi (enzalutamide) significantly improves overall survival in patients with metastatic ...

In the next in our series, GP Dr Roger Henderson debunks common myths about prostate cancer – and highlights some less ...

When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

Sebastian Kaulitzki – stock.adobe.com “Without screening, the number of men diagnosed with advanced prostate cancer – when treatments are less effective – increases fast.” Fox News ...

The 18-gene MyProstateScore 2.0 (MPS2) test using first-catch non-digital rectal examination (DRE) urine is highly se ...

NEW YORK, NY, USA I 13, 2025 I Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), ...

Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, ...

Flatiron Health today announced its planned presence at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), including ...

"Without screening, the number of men diagnosed with advanced prostate cancer – when treatments are less effective – increases fast." Fox News senior medical analyst Dr. Marc Siegel ...